3 documents found, page 1 of 1
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation dev...
Hindricks, Gerhard; Potpara, Tatjana; Dagres, Nikolaos; Arbelo, Elena; Bax, Jeroen J.; Blomström-Lundqvist, Carina; Boriani, Giuseppe; Castella, ManuelAtrial fibrillation (AF) poses significant burden to patients, physicians, and healthcare systems globally. Substantial research efforts and resources are being directed towards gaining detailed information about the mechanisms underlying AF, its natural course and effective treatments (see also the ESC Textbook of Cardiovascular Medicine: CardioMed) and new evidence is continuously generated and published. The...
Rivaroxabananddabigatraninpatientsundergoing catheter ablation of atrial fibril...
Morais, João; Providência, Rui; Boveda, Serge; Jourda, François; Hireche, Hassiba; Combes, Stéphane; Combes, Nicolas; Marijon, Eloi; Albenque, Jean-PaulAims: The recent availability of the novel oral anticoagulants (NOACs) may have led to a change in the anticoagulation regimens of patients referred to catheter ablation of atrial fibrillation (AF). Preliminary data exist concerning dabigatran, but information regarding the safety and efficacy of rivaroxaban in this setting is currently scarce. Methods: and results Of the 556 consecutive eligible patients (age ...
Evaluation of left atrial deformation to predict left atrial stasis in patients...
Providência, Rui; Faustino, Ana; Ferreira, Maria João; Gonçalves, Lino; Trigo, Joana; Botelho, Ana; Barra, Sérgio; Boveda, SergeBackground: Speckle tracking-derived strain and strain rate are recently available parameters to assess left atrial (LA) deformation. We hypothesized that such new parameters could be of interest to evaluate the risk of LA stasis among patients with atrial fibrillation (AF). Methods: Single-centre study enrolling all patients with non-valvular AF lasting longer than 48 hours for whom no therapeutic anticoagulat...